Christine Davis is the President of Ontada, an oncology real world data and technology business dedicated to improving the lives of cancer patients through its life science and provider solutions.

Ms. Davis has more than 25 years of experience in life science consulting, predominately in Oncology. Prior to joining Ontada, Christine was the Global Head of Commercial Research & Consulting at Cerner Enviza (part of Oracle Life Sciences) across 10 countries in North America, Europe, and Asia. In this position she lead Oracle's Data Products in Oncology and Specialty, as well as its Research, Analytics, and Consulting businesses.

Ms. Davis has held various other leadership positions during her tenure at Cerner (formally Kantar Health), including General Manager of Oncology & Specialty, General Manager of Marketing Insights, Chief Operating Officer, and Head of Business Insights (quantitative analytics), first in the U.S., then globally.

Jade Cusick assumes the role of Chief Commercial Officer at Ontada, spearheading client partnerships, commercialization and growth initiatives, along with marketing activities across key customer segments and stakeholders.

Bringing a wealth of experience to his new position, Jade previously held the role of Chief Commercial Officer at Aetion. Prior to that, he served on the executive committee of Cerner Enviza, an Oracle company, where he led client partnerships and commercialization efforts. Notably, he played a pivotal role in the establishment of Cerner Enviza following the merger of Kantar Health, a Bain Capital company, with Cerner's EHR data organization and other research assets. As a key member of the executive team, Jade contributed to the successful sale of Kantar Health to Cerner (NASDAQ:CERN) in April 2021.

With over two decades of experience in consulting within the Life Sciences industry, Jade has collaborated with various biopharma constituents and functions throughout the product lifecycle, spanning commercial strategy and planning, marketing insights, real-world evidence (RWE) and health economics outcomes research (HEOR), clinical operations, regulatory affairs, and safety.

Mick Correll is the President of Genospace, a data science and technology company dedicated to enabling the delivery of precision medicine at scale.

As an entrepreneur, engineer, and scientist, Mick has established himself as a leader in genomic-driven research and medicine.  Having co-founded Genospace in 2011, Mick led the company through two successful acquisitions by leading Fortune 100 healthcare companies, first in a merger with HCA/Sarah Cannon in 2017 and then again with McKesson in 2022.

After earning a B.S. in Computer Science and a B.A. in Molecular Biology from the University of Colorado at Boulder, Mick started his career at European pioneer Lion Bioscience, and U.K.-based informatics provider InforSense. Prior to Genospace, Mick was a leader in establishing the Center for Cancer Computational Biology at the Dana Farber Cancer Institute.

Chris Frey is the assistant general counsel, where she leads the legal team supporting Ontada’s customers, strategies and solutions.

Previously, Chris was assistant general counsel for McKesson’s Prescription Technology Solutions. She also has experience in private practice at a large law firm focused on technology solutions, mergers & acquisitions and public-private partnerships.

Chris holds a J.D. from the University of Michigan, where she graduated cum laude.

“When Ontada succeeds, oncology patients and their care communities will experience unprecedented positive outcomes due to cutting-edge and affordable care driven by the power of data insights.”

C Lyn Fitzgerald is the Senior Vice President, Chief Growth Officer for Ontada.  Lyn leads the development and implementation of strategy and initiatives to drive growth in the life sciences sector, including identifying and pursuing new business opportunities, partnerships, acquisitions, and engagement with key accounts to optimize collaborative opportunities and market presence.

Ms. Fitzgerald previously led the Sales Organization for Ontada’ s full line of Life Sciences and Channel products and partnerships, including Real World Data & Analytics, Real World Research, Consulting and Ontada Learn. has more 25 years of health care sales and business development experience including more than 17 years in Oncology. Prior to joining Ontada, Ms. Fitzgerald spent more than 13 years at the National Comprehensive Cancer Network (NCCN), where she most recently served as Senior Vice President, U.S. & Global Development. During her tenure, Lyn drove the development and successful execution of an innovative business and productization strategy that significantly expanded the reach, utilization, and influence of NCCN content across the entire oncology ecosystem.

Lyn holds a Bachelor of Business Administration and a Master of Journalism in Communications, both from Temple University. She is a frequent national speaker on the role of guidelines in cancer care, a published author of several articles on health and healthcare policy, as well as a contributing author of multiple white papers and task force reports on quality, value, access, data, and evidence-based care in oncology.

“Ontada has the power to transform cancer care by providing life sciences companies and providers with the insights they need to bring innovation to market and ultimately to patients faster. No other organization offers the essential insights of the largest most influential provider network with embedded technology and enriched data sources.”

John Hopkins is the vice president of compliance & ethics for Ontada where he oversees operational compliance, ethics and privacy programs while helping balance the strategic business needs with regulatory and legal requirements.

John joined McKesson in 2013 and has held numerous roles in policy governance, data privacy and compliance leadership in other McKesson technology service lines including Macro Helix and CoverMyMeds.

Prior to McKesson, John worked for WebMD.com for more than 16 years where he helped define, build and oversee WebMD’s compliance & ethics programs for technology services and websites serving consumers, physicians and health plans. He started his life-long career in healthcare as a respiratory therapist in the U.S. Army. His last clinical role as a civilian was at the National Institutes of Health (NIH) in Bethesda, Maryland.

John holds a Bachelor of Science degree in Communications from Kennesaw State University. 

Sagran Moodley is the Chief Innovation and Technology Officer for Ontada. In this role, he is responsible for Ontada’s data infrastructure, integrity, insights, and security as well as the development of the core technologies and systems that power Ontada’s diverse software suites.

Sagran has more than 25 years of experience leading transformative healthcare IT and business initiatives. Most recently, Sagran served as Senior Vice President of Clinical Data Services and Technology for UnitedHealthcare Clinical Services, responsible for the clinical technology strategies for over 55 million members across UnitedHealthcare’s Medicare, Medicaid, and Commercial lines of business.

Sagran has a passion for advancing industry-wide interoperability data exchange standards. He has an active leadership role in several data standardization initiatives. He was the co-founder and current chair of the Da Vinci Project, a private-public sector initiative focusing on clinical data exchange standards (interoperability) between payers and providers supporting value-based care delivery. He also serves on the Health Level Seven (HL7) Advisory Council and is a member of the Executive Steering Committee of the Gravity Project, focusing on standardizing the approach to collecting social determinants of health (SDOH) information from provider organizations.

He holds a B.S. in Computer Science from the University of South Africa and completed graduate study coursework at Harvard Business School in healthcare administration and healthcare delivery.

As the Vice President of Technology Strategy and Operations, Arun leads the Technology Portfolio, Agile Culture, Processes, Governance, Vendor Management, and Tech Finance. He has over 15 years of experience in the healthcare industry, managing complex technology programs and products and delivering value, innovation, and efficiency to patients, and customers. Arun is passionate about leveraging technology to improve healthcare outcomes, access, and affordability.

Prior to McKesson, Arun worked for Cigna as a Senior Director of Technology, leading Global Infrastructure and operations. He led the Agile culture transformation of Cigna and Express Scripts, Tech Product Management, and Program delivery. He was also a Chief of Staff responsible for strategy and operational effectiveness for the Infrastructure Intake, Planning, and Delivery Organization.

Arun holds a Master of Science in manufacturing systems engineering from the Louisiana Tech University. 

Michelle Myers is the Vice President, Head of Life Science Data Products at Ontada. With over 20 years of experience in the healthcare data and technology space, including more than 10 years at McKesson/Ontada, Michelle leads all aspects of product strategy, development, and operations for Ontada's comprehensive line of real-world oncology data products and services.

Throughout her tenure at McKesson/Ontada, Michelle has played a pivotal role in expanding and enhancing the company's oncology real-world data services and capabilities. Her diverse leadership journey within the organization encompasses various critical roles, spanning data and technology product operations and management, product strategy and development, and fostering strategic partnerships for growth and business development.

Michelle's expertise extends across the intricate landscape of biopharmaceutical product development and life cycle management, health policy, and healthcare technology and real-world data in the United States and globally. She has a proven track record of working closely with key stakeholders such as governments, providers, and life science organizations to deliver strategic insights on the efficiencies and effectiveness of various policies, products, and services. Michelle has extensive knowledge of the McKesson oncology ecosystem, technologies, and data further enriches her contributions to Ontada's leadership team.

Before joining McKesson Specialty Health, Michelle spent several years working with governments in the Middle East, focusing on reforming and improving their healthcare systems. Her career journey also includes impactful positions at PwC, Boston Healthcare Associates, the U.S. Department of Health and Human Services Office of Inspector General, and Mathematica Policy Research.

Michelle holds a Master of Public Administration in Health Policy and Research and a Bachelor of Arts in Economics.

Amy K. O’Sullivan, Ph.D., is Senior Vice President and Chief Research Officer at Ontada, where she leads the teams responsible for the delivery of real- world research, real-world data products and analytics, and physician engagement and education to life sciences partners.

Amy is a health economist with over 25 years of experience conducting health economics and outcomes research on medical interventions throughout the product lifecycle. Prior to joining Ontada, she held senior leadership positions at Alkermes, Inc., Vertex Pharmaceuticals, IMS Health, and OptumInsight, where she led research teams and provided scientific expertise on a range of studies in support of product reimbursement in jurisdictions around the world. Amy has authored studies in numerous clinical and health economic peer-reviewed journals, and presented results of her work at scientific congresses across the globe. She holds a BA in Economics and English from Boston College and PhD in Health Economics from Johns Hopkins University School of Public Health.

In addition to her role at Ontada, Amy also serves on the Board of Directors for ISPOR (International Society for Pharmacoeconomics and Outcomes Research), the leading professional society for health economics and outcomes research (HEOR) globally.

Heather is the vice president of human resources for Ontada. In this role, she leads the human resources team and serves as an executive advisor to senior leadership. She is responsible for talent strategy, organization design, and change management and culture.

Heather has been at McKesson for 5 years and served in a variety of roles with increasing responsibility, including roles in Executive Development, Talent and Succession planning, and Sr. Director HR at Ontada. Prior to McKesson, she held Talent Management roles at PepsiCo and FedEx covering areas such as talent management, culture, and learning & development. Heather holds an MBA from Texas Christian University and a BS from the University of Oklahoma.

Nicholas J. Robert is the chief medical officer at Ontada. In this position, he is responsible for deepening Ontada’s clinical focus and expertise. He also collaborates across the organization to ensure studies, real-world data offerings and educational programs maintain the highest scientific standards and clinical relevance.

Nick previously held the role of VP, Medical Affairs at Ontada where he oversaw the development and completion of real-world evidence studies, including the MYLUNG Consortium™ Protocol 1. Nick has spent much of his career as a practicing oncologist, including as Medical Director of the research program at Virginia Cancer Specialists and Clinical Director of Medical Oncology at Tufts Medical Center.

A leader in community oncology, Nick has authored more than 100 publications and serves as a reviewer for medical journals, including the Journal of Clinical Oncology-Clinical Cancer Informatics. He is a member of several industry organizations, including the American Society of Clinical Oncology (ASCO), and is board certified in Internal Medicine, Anatomic Pathology, Medical Oncology, and Hematology.

Nick received his medical degree from McGill Medical School and completed residencies at Royal Victoria Hospital and Massachusetts General Hospital and fellowships at the Brigham and Women’s Hospital and Dana Farber Cancer Institute. He was a Fellow at Harvard Medical School.